Final answer:
Scheduled drugs are identified by a schedule designation on their package label, such as C-II for Schedule II. This indicates the level of control according to their potential for abuse as regulated by the DEA and FDA.
Step-by-step explanation:
Scheduled drugs can be identified by a specific designation on their package label, which indicates their classification under the Controlled Substances Act. This designation is typically a roman numeral or the letter "C" followed by a number (e.g., C-II for Schedule II controlled substances). The packaging of these drugs will prominently display the schedule to which the drug is assigned, signaling restrictions and regulations involving prescription, distribution, and handling. The U.S. Drug Enforcement Administration (DEA) classifies drugs into schedules based on their potential for abuse and dependence, ranging from Schedule I (high potential for abuse, no accepted medical use) to Schedule V (lower potential for abuse, accepted medical use).
The FDA is responsible for the evaluation of new drugs through the New Drug Application (NDA) process and ensures that generic drugs meet the necessary requirements through the Abbreviated New Drug Application (ANDA). The 'schedule' information plays a critical role for healthcare providers, pharmacists, and patients in ensuring that the drug is used appropriately and safely.